xmab24306
Recombinant proteinexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 27, 2020 (NCT04250155)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Interleukin-15AGONIST
IL15 agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05646836 | Phase 1 | Jan 3, 2023 | Genentech, Roche |
| NCT05243342 | Phase 1 | Apr 28, 2022 | Genentech, Roche |
| NCT04250155 | Phase 1 | Jan 27, 2020 | Genentech, Roche |
Showing 3 of 3 trials
Page 1 / 1